Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Notice of Intent contact activation pathway function…

U.S. Department Of Defense·Maryland

Notice of Intent contact activation pathway function blocking antibody AB023

Closes 7/9/2026$100k – $1MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Defense Health Agency (DHA) is issuing a notice of intent to procure contact activation pathway function blocking antibody AB023 via a sole source negotiation with Oregon Health & Science University (OHSU). The North American Industry Classification System (NAICS) code for this requirement is 541714. Interested parties may submit capability information by 09 July 2026 to establish their ability to meet this requirement. The key aspects of this opportunity include: • The procurement of contact activation pathway function blocking antibody AB023 • The sole source negotiation with Oregon Health & Science University (OHSU) • The NAICS code of 541714 • The submission of capability information by interested parties

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Andy Shortall

[email protected]

(301) 619-2212

Key dates

Opened
6/23/2026
Questions due
7/9/2026
Closes
7/9/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
HT9426-26-NOI-WS03

Budget estimate

$100,000 – $1,000,000

The budget for this opportunity is difficult to estimate as the document does not provide a specific dollar amount. However, considering the procurement of a specific biotechnology product, the budget could range from $100,000 to $1,000,000, depending on the quantity and complexity of the product. The factors that may influence the likely payment range include the cost of research and development, production costs, and the potential market value of the product.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Defense·Virginia

Top match · 60%

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Closes 11/5/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

60% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

University of South Carolina·South Carolina

60% match

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

59% match

Notice of Intent: Program to End Modern Slavery FY 2023

Rolling / TBD closeOpened 1/20/2023

Clemson University·South Carolina

58% match

Notice of Intent to Sole Source for Identity Synchronization Platform

Rolling / TBD closeOpened 9/23/2026

U.S. National Institutes of Health·United States of America

58% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. Department Of Defense·Maryland

57% match

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

57% match

Notice of Intent: Program to End Modern Slavery FY 2022

Rolling / TBD closeOpened 1/21/2022

U.S. National Institutes of Health·United States of America

57% match

Functional Target Validation for Alzheimer's Disease-Related Dementias

Closes 11/5/2026Opened 3/11/2026

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

57% match

Notice of Intent: Program to End Modern Slavery FY 2025

Rolling / TBD closeOpened 12/2/2024

Michigan Department of Health and Human Services Procurement Office·Michigan

57% match

Notice of intent to award ITN 270000000002

Closes 11/2/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

57% match

Immune Drivers of Autoimmune Disease

Closes 6/10/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

57% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

Department of Behavioral Health and Developmental Disabilities·South Carolina

57% match

Notice of Intent to Sole Source – Department of Behavioral Health and Developmental Disabilities

Rolling / TBD closeOpened 7/28/2026

University of Mississippi Medical Center·Mississippi

57% match

SS6008 for Non‑human Primate Actigraphy Devices

Closes 11/6/2026Opened 10/19/2026

U.S. Department Of Commerce·United States of America

57% match

NATO Request for Information: Allied Future Surveillance and Control (AFSC) Enhanced Tactical Connectivity (eTacC) Capability

Closes 5/29/2028Opened 4/13/2026

U.S. Department Of Defense·Illinois

57% match

Cornerstone CS-27-0701 Generation 2 Narcotics Destruction Technology

Closes 11/30/2026Opened 10/1/2026

U.S. National Institutes of Health·United States of America

57% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. Department Of Health And Human Services·Maryland

57% match

Notice of Intent to Sole Source: Peer-to-peer Immunization Training and Curriculum Deployment

Closes 11/6/2026Opened 10/23/2026

U.S. Centers for Disease Control-GHC·United States of America

56% match

Capacity Building for Global, Regional, and National Immunization Programs

Closes 3/13/2027Opened 8/14/2026

U.S. National Institutes of Health·United States of America

56% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

56% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

56% match

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. National Institutes of Health·United States of America

56% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Food and Drug Administration·United States of America

56% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023